Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GreenMark Biomedical
AddedFeb 15, 2024
UpdatedJun 18, 2026
GreenMark Biomedical

GreenMark Biomedical

GreenMark: A healthcare firm providing nanoparticle solutions for early dental diagnosis and treatment.

HQ
East Lansing, MI, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize dental care, GreenMark Biomedical focuses on providing nanoparticle solutions for early dental diagnosis and treatment. The company's vision is to transform the dental experience by offering non-invasive products that aid in the early detection and management of oral health issues. Their flagship product, CrystLCare™ Biorestorative, aims to treat dental sensitivity and enhance the visualization of caries disease, promoting painless and natural tooth repair. GreenMark targets dentists, hygienists, and patients seeking proactive and preventative oral health care solutions.

Notable figures affiliated with GreenMark Biomedical include experts in nanotechnology and dental care, although specific names are not provided. The company has garnered attention for its innovative approach to dental health, securing investments from key players in the healthcare and technology sectors. GreenMark's achievements include the successful development and market introduction of CrystLCare™, which has the potential to significantly reduce the need for invasive dental procedures. Overall, GreenMark Biomedical is making a substantial impact by setting new standards in preventative dental care.

GreenMark Biomedical - Similar Companies

NanoMosaic logo

NanoMosaic

Advanced NanoTherapies logo

Advanced NanoTherapies

Crystalplex logo

Crystalplex

Biomat Sciences logo

Biomat Sciences

Oral Genome logo

Oral Genome

oralgenome.com

NanoHybrids logo

NanoHybrids

nanohybrids.net

Curemark logo

Curemark

curemark.com

Nano Cures logo

Nano Cures

nanocures.com

Nanopath logo

Nanopath

nanopathdx.com

Quadric BioMed logo

Quadric BioMed

quadricbiomed.com

Mercy BioAnalytics logo

Mercy BioAnalytics

mercybio.com

Dental Innovations logo

Dental Innovations

NanoDx logo

NanoDx

NanoMedTrix logo

NanoMedTrix

Curated Dental logo

Curated Dental

curateddental.com

GreenMark Biomedical - Quick Facts

Who are GreenMark Biomedical's competitors?

Companies similar to GreenMark Biomedical include NanoMosaic, Advanced NanoTherapies, Crystalplex and Biomat Sciences.

When was GreenMark Biomedical founded?

GreenMark Biomedical was founded in 2016.

Where is GreenMark Biomedical's headquarters located?

GreenMark Biomedical's headquarters is located in East Lansing, MI, US.

How much has GreenMark Biomedical raised to-date?

As of Aug 28, 2023, GreenMark Biomedical has raised a total of $3.7M (USD).

How many employees does GreenMark Biomedical have?

GreenMark Biomedical has 30 employees as of Feb 5, 2024.

GreenMark Biomedical - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Nanotechnology
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Dental Care
  • Diagnostics
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research